💼 Advarra Hiring: Research Analyst I – Clinical Research | Bengaluru (Hybrid) | Freshers
📍 Location: Bengaluru, India (Hybrid)
🎓 Eligibility: B.Pharm / M.Pharm / Pharm.D / M.Sc / B.Sc / Life Sciences
🧪 Experience: 0 – 2 Years
💼 Job Type: Full-Time | Clinical Research | Study Document Analysis | CTMS Support
🔎 Verified: ✅ Verified Job via Medical Jobs India – hitechplus.in
📄 Job Overview
Advarra, a global leader in clinical research, is hiring Research Analyst I in Bengaluru. This role is ideal for freshers and early-career professionals to gain experience in clinical research, study document analysis, and clinical trial support using CTMS systems.
🔬 Key Responsibilities
- ✔ Analyze clinical trial study documents to extract critical data.
- ✔ Work with Clinical Trial Management Software (CTMS) for study support.
- ✔ Collaborate with project managers & cross-functional teams to meet deadlines.
- ✔ Review and optimize existing clinical research content.
- ✔ Ensure compliance with ICH-GCP guidelines and industry standards.
- ✔ Participate in team meetings & problem-solving discussions.
✅ Required Qualifications & Skills
- ✅ Knowledge of clinical research methodology & GCP guidelines.
- ✅ Familiarity with MS Office & business software.
- ✅ Strong organizational & communication skills.
- ✅ 0–2 years experience in clinical data management, pharmacovigilance, or site coordination preferred.
- ✅ Detail-oriented, proactive, and able to work in a culturally diverse environment.
🎁 Benefits of Joining Advarra
- 🌍 Hybrid work model (Bengaluru-based).
- 🤝 Inclusive & supportive team environment.
- 📈 Career growth in clinical research.
- 💰 Competitive salary & benefits.
- 💼 Work with cutting-edge clinical trial solutions and patient-centric culture.
For more Jobs 👇👇
📌 Note Before You Apply:
Highlight clinical research knowledge, CTMS experience, GCP compliance, and document analysis skills in your CV for better selection chances.
👇 Apply Link Will Be Visible in 15 Seconds 👇
🟢 Verified Job via Medical Jobs India – hitechplus.in
0 Comments